"We are delighted that our relentless strife for excellence in the development of our innovative PCFiT technology platform is recognized with this prestigious reward", commented Rainer Henning, CEO of Biomay. "We will continue to work hard to make our lead product BM32 available to grass pollen allergy sufferers as quickly as possible and advance our pipeline products for other allergies into the clinic."
Biomay Named Winner of Corporate LiveWire Healthcare and Lifesciences Innovation Award
The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.
As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.